MAGI2 is an independent predictor of biochemical recurrence in prostate cancer

MAGI-2 Is a Sensitive and Specific Marker of Prostatic Adenocarcinoma

(2016) Jeffery Goldstein et al.   AMERICAN JOURNAL OF CLINICAL PATHOLOGY

MAGI-2 in prostate cancer: an immunohistochemical study

(2016) Jeffery Goldstein et al.   HUMAN PATHOLOGY

Integrative Clinical Genomics of Advanced Prostate Cancer

(2015) Dan Robinson et al.   CELL

PTEN loss in biopsy tissue predicts poor clinical outcomes in prostate cancer

(2014) Prabhakar Mithal et al.   INTERNATIONAL JOURNAL OF UROLOGY

Tumour genomic and microenvironmental heterogeneity for integrated prediction of 5-year biochemical recurrence of prostate cancer: a retrospective cohort study

(2014) Emilie Lalonde et al.   LANCET ONCOLOGY

PTEN loss is associated with upgrading of prostate cancer from biopsy to radical prostatectomy

(2014) Tamara L Lotan et al.   MODERN PATHOLOGY

Expression profile of MAGI2 gene as a novel biomarker in combination with major deregulated genes in prostate cancer

(2014) Reza Mahdian et al.   MOLECULAR BIOLOGY REPORTS

Copy number alteration burden predicts prostate cancer relapse

(2014) H. Hieronymus et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

CHD1 Is a 5q21 Tumor Suppressor Required for ERG Rearrangement in Prostate Cancer

(2013) L. Burkhardt et al.   CANCER RESEARCH

Punctuated Evolution of Prostate Cancer Genomes

(2013) Sylvan C. Baca et al.   CELL

MAGI2 enhances the sensitivity of BEL-7404 human hepatocellular carcinoma cells to staurosporine-induced apoptosis by increasing PTEN stability

(2013) XIN LI et al.   INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE

Exome sequencing identifies recurrent SPOP, FOXA1 and MED12 mutations in prostate cancer

(2012) Christopher E Barbieri et al.   NATURE GENETICS

ROS enhances CXCR4-mediated functions through inactivation of PTEN in prostate cancer cells

(2011) Mahandranauth A. Chetram et al.   BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS

The genomic complexity of primary human prostate cancer

(2011) Michael F. Berger et al.   NATURE

Integrative Genomic Profiling of Human Prostate Cancer

(2010) Barry S. Taylor et al.   CANCER CELL